In September 2000, Dr. Shrotriya joined Spectrum Pharmaceuticals as President and Chief Operating Officer and in August 2002, he was appointed Chief Executive Officer.In this capacity he has spearheaded major changes in business strategy and coordinated structural reorganization culminating in the formation of Spectrum Pharmaceuticals, Inc.
Previously, Dr. Shrotriya was Executive Vice President and Chief Scientific Officer for SuperGen, Inc. and Vice President, Medical Affairs and Vice President, Chief Medical Officer at MGI Pharma, Inc. For 18 years he held various positions at Bristol-Myers Squibb Company, the most recent being Executive Director Worldwide CNS Clinical Research.
This biography and more information about Spectrum Pharmaceuticals can be found on their website.
